Cargando…
Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway
BACKGROUND: For people with opioid dependence in Norway, chronic hepatitis C virus (HCV) infections contribute to high mortality and high morbidity. Around 50% of patients in medically assisted rehabilitation (MAR) have been shown to have HCV, and the current prevention and control efforts have been...
Autores principales: | Lygren, Ole Jørgen, Bjørnestad, Ronny, Løberg, Else-Marie, Bonnier, Martine Lepsøy, Buljovcic, Vibeke Bråthen, Johansson, Kjell Arne, Fadnes, Lars T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925489/ https://www.ncbi.nlm.nih.gov/pubmed/31864396 http://dx.doi.org/10.1186/s13011-019-0245-y |
Ejemplares similares
-
Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022) -
Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
por: Chalabianloo, Fatemeh, et al.
Publicado: (2021) -
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019) -
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021) -
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2020)